A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer. (Q65379491)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer. |
clinical trial |
Statements
A Randomized, Open Label Study to Compare the Complete Pathological Response Rate Achieved With 4 Combinations of Herceptin, Docetaxel and Pertuzumab in Patients With Locally Advanced, Inflammatory or Early Stage HER2 Positive Breast Cancer (English)
0 references
26 June 2006
0 references
22 September 2014
0 references
417
0 references
18 year
0 references